Arkolith/Insider Trading/TTOO/Form 4

Giffin Brett A.

Chief Commercial OfficerT2 Biosystems, Inc. (TTOO) · full profile →Form 4 · filed Feb 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2024Option exercise(M)13——77

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 20, 2024Grant(A)13—$013

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-017069) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML